Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Callan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advances in Radiation Oncology|February 2, 2019
Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the LiteratureLaura Callan, Stewart Gaede, Alexander V Louie
Gynecologic Oncology Reports|March 1, 2019
Metastatic cervical adenocarcinoma to the breast: A case report and literature reviewKaren Cholmondeley, Laura Callan, Nikhil Sangle, et al.
Advances in Radiation Oncology|November 5, 2019
A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity AnalysisLaura Callan, Glenn Bauman, Jeff Chen, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Prognostic Index for Liver Radiation (PILiR)Laura Callan, Haddis Razeghi, Natalie Grindrod, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advances in Radiation Oncology|February 2, 2019
Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the LiteratureLaura Callan, Stewart Gaede, Alexander V Louie
Gynecologic Oncology Reports|March 1, 2019
Metastatic cervical adenocarcinoma to the breast: A case report and literature reviewKaren Cholmondeley, Laura Callan, Nikhil Sangle, et al.
Advances in Radiation Oncology|November 5, 2019
A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity AnalysisLaura Callan, Glenn Bauman, Jeff Chen, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Prognostic Index for Liver Radiation (PILiR)Laura Callan, Haddis Razeghi, Natalie Grindrod, et al.
Pageof 1